Ollie’s Bargain Outlet (NASDAQ:OLLI – Free Report) had its target price boosted by Royal Bank of Canada from $100.00 to $106.00 in a research report released on Wednesday morning, Benzinga reports. Royal Bank of Canada currently has an outperform rating on the stock. Other equities research analysts have also recently issued reports about the stock. […]

Amneal Pharmaceuticals (NASDAQ:AMRX – Free Report) had its price objective raised by Truist Financial from $10.00 to $12.00 in a report issued on Wednesday, Benzinga reports. The firm currently has a buy rating on the stock. A number of other research firms have also weighed in on AMRX. Barclays increased their target price on shares […]

BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report) had its price target dropped by equities researchers at Royal Bank of Canada from $85.00 to $80.00 in a research note issued on Friday, Benzinga reports. The firm presently has a “sector perform” rating on the biotechnology company’s stock. Royal Bank of Canada’s price objective would indicate a […]

Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) had its price objective lowered by Royal Bank of Canada from $136.00 to $133.00 in a research note issued to investors on Friday, Benzinga reports. The brokerage presently has a “sector perform” rating on the stock. Royal Bank of Canada’s target price would indicate a potential upside of […]